Literature DB >> 21929978

Partial splenectomy but not total splenectomy preserves immunoglobulin M memory B cells in mice.

Elisabeth T Tracy1, Karen M Haas, Tracy Gentry, Melissa Danko, Joseph L Roberts, Joanne Kurtzberg, Henry E Rice.   

Abstract

PURPOSE: The mechanism by which partial splenectomy preserves splenic immune function is unknown. Immunoglobulin (Ig) M memory B cells are critical for the immune response against encapsulated bacteria and are reduced in asplenic patients, although it is unknown whether partial splenectomy can preserve memory B cells. We hypothesized that IgM memory B cells (murine B-1a cells) would be preserved after partial splenectomy but not after total splenectomy in mice.
METHODS: We performed total splenectomy (n = 17), partial splenectomy (n = 10), or sham laparotomy (n = 16) on C57BL/6J mice. Mice were killed on postoperative day 10 or 30, and peritoneal washings were analyzed by multiparameter flow cytometry for expression of murine B-1a cells (IgM(pos)IgD(dull)CD5(pos)B220(dull)).
RESULTS: We found that B-1a cells were significantly reduced after both total and partial splenectomies compared with sham laparotomy in the early postoperative period, although normal levels of B-1a cells returned by postoperative day 30 in mice undergoing partial splenectomy but not total splenectomy.
CONCLUSION: Partial splenectomy but not total splenectomy preserves the B-1a B-cell population in mice within 30 days after surgery. Maintenance of these critical B cells may contribute to the preservation of a splenic-dependent immune response after partial splenectomy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21929978     DOI: 10.1016/j.jpedsurg.2011.04.020

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Feasibility and Safety of Laparoscopic Partial Splenectomy: A Systematic Review.

Authors:  Gangshan Liu; Ying Fan
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

2.  The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse.

Authors:  Megan Laudenbach; Federico Baruffaldi; Jeffrey S Vervacke; Mark D Distefano; Philip J Titcombe; Daniel L Mueller; Noah J Tubo; Thomas S Griffith; Marco Pravetoni
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

3.  Laparoscopic partial splenectomy is safe and effective in patients with focal benign splenic lesion.

Authors:  Xin Wang; Mingjun Wang; Hua Zhang; Bing Peng
Journal:  Surg Endosc       Date:  2014-06-18       Impact factor: 4.584

4.  Splenectomy Alters Distribution and Turnover but not Numbers or Protective Capacity of de novo Generated Memory CD8 T-Cells.

Authors:  Marie T Kim; John T Harty
Journal:  Front Immunol       Date:  2014-11-06       Impact factor: 7.561

5.  Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA.

Authors:  Esam Khanfar; Katalin Olasz; Erzsébet Gajdócsi; Xinkai Jia; Timea Berki; Péter Balogh; Ferenc Boldizsár
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

6.  B-1a Cell Development in Splenectomized Neonatal Mice.

Authors:  Gabriel K Pedersen; Xiaohong Li; Sharesta Khoenkhoen; Monika Ádori; Bruce Beutler; Gunilla B Karlsson Hedestam
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

7.  The non-coding RNome after splenectomy.

Authors:  Mihnea P Dragomir; Stefan Tudor; Keishi Okubo; Masayoshi Shimizu; Meng Chen; Dana Elena Giza; William Ruixian He; Cristina Ivan; George A Calin; Catalin Vasilescu
Journal:  J Cell Mol Med       Date:  2019-09-08       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.